Intensity Therapeutics, Inc., (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using ...

Reality is far stranger than it appears. Join us as we explore mind-bending discoveries that completely reshape how we ...

Attachment to smart devices and biometric surveillance leaves Americans more vulnerable to police searches than ever. Left ...

First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)Approval is based on ...